Genesem제너셈
217190 · KOSDAQ · ₩217190 · 제너셈
₩7,840▼ ₩530 (6.33%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩23B | ₩6.7B | ₩14B | ₩16B | ₩19B | ₩8.4B | ₩15B | ₩15B |
| Cost of sales | ₩13B | ₩4.1B | ₩8.7B | ₩11B | ₩12B | ₩4.8B | ₩9.8B | ₩8.5B |
| Gross profit | ₩10B | ₩2.7B | ₩5.2B | ₩5.1B | ₩6.8B | ₩3.6B | ₩5.2B | ₩6.2B |
| Operating income | ₩4.2B | −₩2.5B | ₩54M | −₩372M | ₩2.7B | −₩1.3B | ₩1.2B | ₩164M |
| Net income | ₩1.1B | −₩1.7B | ₩786M | −₩10M | ₩1.4B | −₩1.3B | ₩2.1B | −₩487M |
| Net income to shareholders | ₩1.1B | −₩1.7B | ₩786M | −₩23M | ₩1.4B | −₩1.2B | ₩2.1B | −₩532M |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩97B | ₩87B | — | ₩85B | ₩86B | ₩86B | ₩86B | ₩84B |
| Current assets | ₩57B | ₩47B | — | ₩42B | ₩41B | ₩43B | ₩43B | ₩43B |
| Cash and equivalents | ₩4.1B | ₩8.4B | — | ₩15B | ₩11B | ₩14B | ₩20B | ₩13B |
| Total liabilities | ₩48B | ₩39B | — | ₩35B | ₩37B | ₩38B | ₩37B | ₩38B |
| Current liabilities | ₩41B | ₩34B | — | ₩29B | ₩31B | ₩31B | ₩30B | ₩31B |
| Borrowings | ₩20B | ₩16B | — | ₩16B | ₩16B | ₩17B | ₩17B | ₩17B |
| Total equity | ₩49B | ₩48B | — | ₩49B | ₩49B | ₩48B | ₩50B | ₩46B |
| Shareholders' equity | ₩49B | ₩48B | — | ₩49B | ₩49B | ₩48B | ₩50B | ₩47B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩7.3B | −₩7.7B | −₩336M | ₩2.1B | ₩873M | −₩4.8B | ₩8B | ₩185M |
| Free cash flow | −₩7.3B | −₩7.7B | −₩336M | ₩2.1B | ₩873M | −₩4.8B | ₩8B | ₩185M |
| Dividends paid | ₩0 | ₩658M | ₩0 | ₩0 | ₩1.3B | −₩658M | ₩0 | ₩0 |
Consolidated where available. Amounts in won.
Also known as: Genesem / 제너셈 / 217190 / KRX:217190
Source: KRX statistical information